Nonetheless, for new GLP-1 drugs in development, it is imperative to evaluate potential drug interactions since this drug class can alter the efficacy of concomitant medications or increase the risk of adverse events as a result of higher exposure to a co-administrated drug
In a related mechanism focusing on the gut-brain axis, Guo et al
Product Diversification: The food industry is increasingly exploring how to diversify its product offerings to address the specific nutritional needs of GLP-1 medication users, without disrupting its core product line
Gut hormone (GLP-1) and inflammatory indices were measured in human plasma samples using sandwich enzyme linked immunosorbent assays (ELISAs)
In Model 2, higher ProBDNF levels were associated with cocaine use (a = 23.59, 95% CI: 3.6943.49, p = 0.023), psychopharmaceutical intake (a = 42.71, 95% CI: 19.9565.46, p = 0.001), and previous psychiatric hospitalization (a = 60.64, 95% CI: 27.0194.26, p = 0.001), whereas a previous psychiatric diagnosis was negatively associated with the outcome (a = 43.43, 95% CI: 66.76 to 20.10, p = 0.001)
